Want to see GSK full AI Analyst Report?
GlaxoSmithKline (GSK) Ownership Overview
6.17% Mutual Funds
7.96% Other Institutional Investors
0.35% ETFs
85.52% Public Companies and
Individual Investors
The ownership structure of GlaxoSmithKline (GSK) stock is a mix of institutional, retail, and individual investors. Approximately 14.48% of the company’s stock is owned by Institutional Investors, and 85.52% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $77749239 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $4273645 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $375484 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $26428644 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 48,197,514 | Institution | 2.38% | 2,420,479,153 | |
| 47,215,672 | Institution | 2.33% | 2,371,171,048 | |
| 35,722,792 | Institution | 1.77% | 1,793,998,614 | |
| 25,182,068 | Institution | 1.24% | 1,264,643,455 | |
| 18,147,650 | Institution | 0.90% | 911,374,983 | |
| 9,185,065 | Institution | 0.45% | 461,273,964 | |
| 7,943,164 | Institution | 0.39% | 398,905,696 | |
| 5,537,594 | Institution | 0.27% | 278,097,971 | |
| 4,089,400 | Institution | 0.20% | 205,369,668 | |
| 3,544,080 | Institution | 0.18% | 177,983,698 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 47,215,672 | Institution | 2.33% | 2,371,171,048 | |
| 18,147,650 | Institution | 0.90% | 911,374,983 | |
| 9,185,065 | Institution | 0.45% | 461,273,964 | |
| 7,943,164 | Institution | 0.39% | 398,905,696 | |
| 5,537,594 | Institution | 0.27% | 278,097,971 | |
| 4,089,400 | Institution | 0.20% | 205,369,668 | |
| 3,544,080 | Institution | 0.18% | 177,983,698 | |
| 3,442,475 | Institution | 0.17% | 172,881,095 | |
| 2,948,967 | Institution | 0.15% | 148,097,123 | |
| 2,734,200 | Institution | 0.14% | 137,311,524 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,422,642 | Institution | 0.07% | 72,640,101 | |
| 1,154,629 | Institution | 0.06% | 57,985,468 | |
| 856,651 | Institution | 0.04% | 43,740,600 | |
| 660,571 | Institution | 0.03% | 33,173,876 | |
| 324,722 | Institution | 0.02% | 16,580,305 | |
| 300,053 | Institution | 0.01% | 15,320,706 | |
| 228,772 | Institution | 0.01% | 16,340,688 | |
| 228,772 | Institution | 0.01% | 16,340,688 | |
| 213,888 | Institution | 0.01% | 10,921,121 | |
| 185,569 | Institution | <0.01% | 9,319,275 |
FAQ
Who Owns GlaxoSmithKline (GSK)?
Currently, no data Available
What percentage of GlaxoSmithKline (GSK) stock is held by institutional investors?
According to the latest TipRanks data, approximately 7.96% of GlaxoSmithKline (GSK) stock is held by institutional investors.
What percentage of GlaxoSmithKline (GSK) stock is held by retail investors?
According to the latest TipRanks data, approximately 85.52% of GlaxoSmithKline (GSK) stock is held by retail investors.
Who owns the most shares of GlaxoSmithKline (GSK)?
John A. Gunn owns the most shares of GlaxoSmithKline (GSK).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.